The World Health Organization (WHO) says the R21/Matrix-M malaria vaccine given provisional approval by the National Agency for Food and Drug Administration and Control (NAFDAC) still needs to undergo more trials.
The trials are to be recommended by WHO.
WHO Country Representative to Nigeria…
